{"id":829650,"date":"2025-03-25T16:12:34","date_gmt":"2025-03-25T20:12:34","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\/"},"modified":"2025-03-25T16:12:34","modified_gmt":"2025-03-25T20:12:34","slug":"regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\/","title":{"rendered":"Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"start\">TARRYTOWN, N.Y., March  25, 2025  (GLOBE NEWSWIRE) &#8212; Regeneron Pharmaceuticals, Inc. (NASDAQ:<strong> REGN<\/strong>) today announced that it will report its first quarter 2025 financial and operating results on Tuesday, April 29, 2025, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day.<\/p>\n<p align=\"start\">\n        <strong>Conference Call Information<\/strong><br \/>\n        <br \/> Participants may access the conference call live via webcast on the \u2019Investors and Media\u2019 page of Regeneron\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CZddGs8o4D9PTT4_Q_4bRN0Gx7p_ER53eXjbvT2AL70oKkciXV2GPoXGrJUnQHwTxts9uL-tR_E11Rqtg2Y1JhVCvfcwxhQY9x8BIgx2-FNq1Zm528ZYlVW6lKJJgLb-\" rel=\"nofollow\" target=\"_blank\"><u>https:\/\/inve<\/u><u>s<\/u><u>t<\/u><u>o<\/u><u>r<\/u><u>.r<\/u><u>e<\/u><u>generon.com<\/u><\/a>. To participate via telephone, please register in advance at this <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=S1mjYY1cQU6yohnoXfQpT1_zlT67BObw1wxfQzunx_2oTtfGVEDMBka8Ak7BGt6N_wOH1Q2oXyAtCjunwMYb-OzbymPylt1tAnChrky0jooCjnTDJvzUCv6x6_8HM78_ZWduGMzICLe-HLURf7oPnt2YM_wJcdT7q1yL9H99cLg=\" rel=\"nofollow\" target=\"_blank\"><u>link<\/u><\/a>. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay and transcript of the conference call and webcast will be archived on the Company\u2019s website for at least 30 days.<\/p>\n<p align=\"start\">\n        <strong>About Regeneron<\/strong><br \/>\n        <br \/> Regeneron\u00a0(NASDAQ: REGN) is a leading biotechnology company that invents,\u00a0develops\u00a0and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to\u00a0repeatedly and consistently translate science\u00a0into medicine has led to numerous approved treatments and\u202fproduct candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious\u00a0diseases, and rare diseases.\u00a0<\/p>\n<p align=\"start\">Regeneron pushes the boundaries of scientific discovery and accelerates drug development using our proprietary technologies, such as <em>VelociSuite<\/em><sup><em>\u00ae<\/em><\/sup>, which produces optimized fully human antibodies and new classes of bispecific antibodies.\u202fWe are shaping the next frontier of medicine with data-powered insights from the\u202fRegeneron Genetics Center<sup>\u00ae<\/sup>\u202fand pioneering genetic medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases.<\/p>\n<p align=\"start\">For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lLyGzK6kQ8c-Zqv_4rb56YsEaxd-zZ0GPOcGQrRALo8shtQ8Y7T7EK_PjwisHMIVqUGqw4Lb8GX46cF0kFgEF3JzhDb_tMnwp9-ATYhHgxM=\" rel=\"nofollow\" target=\"_blank\"><u>www.Regeneron.com<\/u><\/a> or follow Regeneron on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CuV6fpThF6uPTM7MZ3UWpitZL1PkSRVQUsy6o9bxiIeB8Y07UXUAUpBokkA0ba6yKcpPnWNmRnWKgyvtBhnAsMGyAWPcpJK-XZBHTXNh0Gm3eu9MI-kn7zC-aM60VkoO61fDGSAn6DulqSoHaQ7NZI9v8c4M7v_GRYBBBBazePY=\" rel=\"nofollow\" target=\"_blank\"><u>LinkedIn<\/u><\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Tc1_0KOPiw32BEDKCeYtIZIX2roxujJxEm8JGZXSajyDpVUCBc9E-EO4nl5lT8dHY3JzEa__0u_AkRDolCH7MUh56AgkVqAuQwsFGNi1s2K9oOx0TT9_MGif-Cd_-qvP_F38tFSMJx1lzNeP1t3ki3qe-FOCeW_1hfDJUsEcChVtZKGc9MyafNMmll38m5cIpU2OMRv1MUeAtl_JBJKwv-189pa4ztcyia6Oci0xi095QzrHp3vW6AtJS-iddF0P\" rel=\"nofollow\" target=\"_blank\"><u>Instagram<\/u><\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=36Q5JVuGvKKUv6SAUxoRb2eJVsdBfkqYCvBZgbwE6Kb4VjQLIL3Lu5LfM8yjnhvyym2LPkDdKp0dVzvrBND45hOfpRxAptE3EVqiFNTNtZBeKC71oeMytHwcfajKO9VFsAVv2pTstoafqGHG9fVLRSuA0Zgvt5i-Ekd87NKYtZpA41BD-KrHBptzOWKBfHZtLEyI8a0dddvgoHzBlShGPcWCPxw1sVt3KhSYWomNO7--dxx8B5-eiZOkSrM5-PrG\" rel=\"nofollow\" target=\"_blank\"><u>Facebook<\/u><\/a> or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Q7_41qJicIEwZEJAnd_fHMN3x73bXJtIpiR1toKRX1NBckl3sQhE1xTDyuxe8UXn1d7rd1G-Tbquwt_s6Xc9Hpbdq2KSUVvOxaOW-aNeZOpn9lNILWgX4AKm-cjBmGvNqjaeiaSC_XWNQ8pQQz8NIHOK7TmW-X7i3V2Lk7bj9vFSWiNcymvkjxJKA0YPBbqhG98X3lmCNbvJaGP2YXPtnw==\" rel=\"nofollow\" target=\"_blank\"><u>X<\/u><\/a>.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:50%;width:50%;min-width:50%\">\n            <strong>Contact Information:<\/strong>\n          <\/td>\n<td style=\"max-width:50%;width:50%;min-width:50%\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td>Investor Relations<\/td>\n<td>Corporate Communications<\/td>\n<\/tr>\n<tr>\n<td>Ryan Crowe<\/td>\n<td>Christina Chan<\/td>\n<\/tr>\n<tr>\n<td>914.847.8790<\/td>\n<td>914.847.8827<\/td>\n<\/tr>\n<tr>\n<td>\n            <a href=\"mailto:ryan.crowe@regeneron.com\" rel=\"nofollow\" target=\"_blank\">ryan.crowe@regeneron.com<\/a>\u00a0<\/td>\n<td>\n            <a href=\"mailto:christina.chan@regeneron.com\" rel=\"nofollow\" target=\"_blank\">christina.chan@regeneron.com<\/a>\u00a0<\/td>\n<\/tr>\n<\/table>\n<p align=\"start\">\n        <strong>\u00a0 \u00a0 \u00a0 \u00a0\u00a0<\/strong><br \/>\n        <br \/>\u00a0 \u00a0 \u00a0 \u00a0\u00a0<br \/>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<br \/>\u00a0 \u00a0 \u00a0 \u00a0\u00a0<br \/>\u00a0 \u00a0 \u00a0 \u00a0\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5NzI1NiM2ODE0MTM5IzIwMDYyNTA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MzNlOTU3OGYtMTI4MS00ZTlhLWJjZmItNTZiMjI0MmJlNGEwLTEwMTc4MjMtMjAyNS0wMy0yNS1lbg==\/tiny\/Regeneron-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>TARRYTOWN, N.Y., March 25, 2025 (GLOBE NEWSWIRE) &#8212; Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its first quarter 2025 financial and operating results on Tuesday, April 29, 2025, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day. Conference Call Information Participants may access the conference call live via webcast on the \u2019Investors and Media\u2019 page of Regeneron\u2019s website at https:\/\/investor.regeneron.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-829650","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"TARRYTOWN, N.Y., March 25, 2025 (GLOBE NEWSWIRE) &#8212; Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its first quarter 2025 financial and operating results on Tuesday, April 29, 2025, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day. Conference Call Information Participants may access the conference call live via webcast on the \u2019Investors and Media\u2019 page of Regeneron\u2019s website at https:\/\/investor.regeneron.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can &hellip; Continue reading &quot;Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-25T20:12:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5NzI1NiM2ODE0MTM5IzIwMDYyNTA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025\",\"datePublished\":\"2025-03-25T20:12:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\\\/\"},\"wordCount\":359,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5NzI1NiM2ODE0MTM5IzIwMDYyNTA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\\\/\",\"name\":\"Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5NzI1NiM2ODE0MTM5IzIwMDYyNTA=\",\"datePublished\":\"2025-03-25T20:12:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5NzI1NiM2ODE0MTM5IzIwMDYyNTA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5NzI1NiM2ODE0MTM5IzIwMDYyNTA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\/","og_locale":"en_US","og_type":"article","og_title":"Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025 - Market Newsdesk","og_description":"TARRYTOWN, N.Y., March 25, 2025 (GLOBE NEWSWIRE) &#8212; Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its first quarter 2025 financial and operating results on Tuesday, April 29, 2025, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day. Conference Call Information Participants may access the conference call live via webcast on the \u2019Investors and Media\u2019 page of Regeneron\u2019s website at https:\/\/investor.regeneron.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can &hellip; Continue reading \"Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-25T20:12:34+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5NzI1NiM2ODE0MTM5IzIwMDYyNTA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025","datePublished":"2025-03-25T20:12:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\/"},"wordCount":359,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5NzI1NiM2ODE0MTM5IzIwMDYyNTA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\/","name":"Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5NzI1NiM2ODE0MTM5IzIwMDYyNTA=","datePublished":"2025-03-25T20:12:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5NzI1NiM2ODE0MTM5IzIwMDYyNTA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5NzI1NiM2ODE0MTM5IzIwMDYyNTA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/829650","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=829650"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/829650\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=829650"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=829650"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=829650"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}